Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Metabolism. 2014 Mar 5;63(5):727–734. doi: 10.1016/j.metabol.2014.03.001

TABLE 2.

Differences in the lipid measurements in this study between the diabetic subjects with and without high triglyceride levels

Metabolic Measurements Diabetic Participants
with
Hypertriglyceridemia
(n=45) Group 1		 Diabetic Participants
without
Hypertriglyceridemia
(n=26) Group 2
Hemoglobin A1c (%) 8 ± 2 8 ± 2 0.28
HDL cholesterol (mg/dL) 44 ± 11 50 ± 13 0.04
LDL cholesterol (mg/dL) 112 ± 33 106 ± 30 0.41
Triglycerides (mg/dL) 226 ± 88 91 ± 22 < 0.0001
Apo A-I (mg/dL) 135 ± 19 138 ± 40 0.8
CETP activity (MFI)* 417 ± 251 335 ± 129 0.02
PLTP activity (MFI)* 45.3 ± 17.8 39.8 ± 10.5 0.05
LCAT activity (MFI)* 1.41± 0.19 1.42± 0.12 0.6
Efflux Ratio (Normalized)** 1.17 ± 0.25 1.03 ± 0.19 0.0098

Data are means ± SD

*

: Median Fluorescence Intensity

**

Efflux measurements were normalized to a standard pool and reported as ratios.